VIVS Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
18.0K
-55.0%
40.0K
+53.8%
26.0K
-7.1%
28.0K
-24.3%
37.0K
Cost of Revenue
0
0
0
0
0
Gross Profit
18.0K
-55.0%
40.0K
+53.8%
26.0K
-7.1%
28.0K
-24.3%
37.0K
Operating Expenses
2.8M
-13.9%
3.2M
+16.2%
2.8M
+4.2%
2.7M
-9.8%
3.0M
R&D
1.1M
+0.6%
1.1M
-1.3%
1.1M
+23.5%
923.0K
-7.8%
1.0M
SG&A
1.6M
-21.7%
2.1M
+28.5%
1.6M
-6.0%
1.7M
-10.8%
2.0M
Operating Income
-2759000
+13.4%
-3187000
-15.9%
-2750000
-4.4%
-2635000
+9.6%
-2915000
EBITDA
-2719000
+13.5%
-3144000
-16.5%
-2698000
-4.7%
-2576000
+9.7%
-2854000
Net Income
-1338000
+76.8%
-5764000
-114.2%
-2691000
-5.7%
-2545000
+10.5%
-2843000
EPS (Basic)
$-0.25
+88.6%
$-2.19
-112.6%
$-1.03
-5.1%
$-0.98
+14.0%
$-1.14
EPS (Diluted)
$-0.25
+88.6%
$-2.19
-112.6%
$-1.03
-5.1%
$-0.98
+14.0%
$-1.14
Shares (Diluted)
5.2M
+98.7%
2.6M
+1.1%
2.6M
+0.1%
2.6M
+4.0%
2.5M
VivoSim Labs (VIVS) — Financials